
The potential ischemic benefits of novel oral antiplatelet therapy following an acute coronary syndrome (ACS) may be offset by a significant increase in major bleeding events, according to a meta-analysis recently published in the Archives of Internal Medicine. “We are already exposing these patients to several drugs that can produce…
Read more »
Landmark Trial in Tamil Nadu Reduces Mortality Due to Heart Attack – TN STEMI Program Shows the Way Forward for a National Heart Attack Program
India is a large country with a very high burden of non-communicable disease, particularly cardiovascular diseases. It is estimated that there are over 60 million patients with heart disease in India with…
Read more »